Abstract
myo-Inositol is elevated in the Down syndrome (DS; trisomy 21) brain and may play a role in mental retardation. In the present study, we examined brain regions and peripheral tissues of Ts65Dn mouse, a recently characterized genetic model of DS, for abnormal myo-inositol accumulation. A GC/MS technique was used to quantitate myo-inositol and other polyol species (ribitol, arabitol, xylitol, and 1,5-anhydrosorbitol) in tissues from the Ts65Dn mice and control diploid mice. myo-Inositol was found to be elevated in frontal cortex, hippocampus, and brain stem but not in cerebellum of the Ts65Dn mouse. Among peripheral organs examined, liver and skeletal muscle were found to excessively accumulate myo-inositol. In all tissues, concentrations of polyol internal controls were normal. The Ts65Dn mouse is useful to study the possible effect of elevated myo-inositol on cellular processes.
Similar content being viewed by others
REFERENCES
Gropp, A., Kolbus, U., and Giers, D. 1975. Systematic approach to the study of trisomy in the mouse. II. Cytogenet. Cell Genet. 14:42–62.
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., and Davisson, M. T. 1995. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nature Genetics 11:177–184.
Shetty, H. U., Schapiro, M. B., Holloway, H. W., and Rapoport, S. I. 1995. Polyol profiles in Down syndrome: myo-inositol, specifically, is elevated in the cerebrospinal fluid. J. Clin. Invest. 95:542–546.
Shetty, H. U., Huang, W., and Schapiro, M. B. 1998. myo-Inositol is elevated in Down syndrome postmortem brain. I. Neurochem. 70:S66C.
Alexander, G. E., Huang, W., Krasuski, J. S., Szczepanik, J., Pietrini, P., Furey, M. L., Levine, B., Prasad, K., Mentis, M. J., Rapoport, S. I., and Schapiro, M. B. 1997. Elevated brain myoinositol correlates with cognition in non-demented Down syndrome adults. Soc. Neurosci. Abstr. 23:859.
Berry, G. T., Mallee, J. J., Kwon, H. M., Rim, J. S., Mulla, W. R., Muenke, M., and Spinner, N. B. 1995. The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Genomics 25:507–513.
Shi, Y.-P., Huang, T.-T., Carlson, E. J., and Epstein, C. J. 1994. The mapping of transgenes by fluorescence in situ hybridization on G-banded mouse chromosomes. Mamm. Genome 5:337–341.
Siarey, R. J., Stoll, J., Rapoport, S. I., and Galdzicki, Z. 1997. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology 36:1549–1554.
Galdzicki, Z., Coan, E., and Rapoport, S. I. 1993. Cultured hippocampal neurons from trisomy 16 mouse, a model for Down' syndrome, have an abnormal action potential due to a reduced inward sodium current. Brain Res. 604:69–78.
Shetty, H. U., Holloway, H. W., and Rapoport, S. I. 1995. Capillary gas chromatography combined with ion trap detection for quantitative profiling of polyols in cerebrospinal fluid and plasma. Anal. Biochem. 224:279–285.
Spector, R., and Lorenzo, A. V. 1975. Myo-inositol transport in the central nervous system. Am. J. Physiol. 228:1510–1518.
Wiese, T. J., Dunlap, J. A., Conner, C. E., Grzybowski, J. A., Lowe, Jr., W. L., and Yorek, M. A. 1996. Osmotic regulation of Na-myo-inositol cotransporter mRNA level and activity in endothelial and neural cells. Am. J. Physiol. 270:C990-C997.
Strange, K., Emma, F., Paredes, A., and Morrison, R. 1994. Osmoregulatory changes in myo-inositol content and Na+/myo-inositol cotransport in rat cortical astrocytes. Glia 12:35–43.
Minami, Y., Inoue, K., Shimada, S., Morimura, H., Miyai, A., Yamauchi, A., Matsunaga, T., and Tohyama, M. 1996. Rapid and transient up-regulation of Na+/myo-inositol cotransporter transcription in the brain of acute hypernatremic rats. Mol. Brain Res. 40:64–70.
Ibsen, L., and Strange, K. 1996. In situ localization and osmotic regulation of the Na+-myo-inositol cotransporter in rat brain. Am. J. Physiol. 271:F877-F885.
Galdzicki, Z., Coan, E. J., Rapoport, S. I., and Stoll, J. 1998. Increased expression of voltage-activated calcium channels in cultured hippocampal neurons from mouse trisomy 16, a model for Down syndrome. Mol. Brain Res. 56:200–206.
Acevedo, L. D., Holloway, H. W., Rapoport, S. I., and Shetty, H. U. 1997. Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: effect of trisomy 16. J. Mass Spectrom. 32:395–400.
Huang, W., Alexander, G. E., Daly, E. M., Shetty, H. U., Krasuski, J. S., Rapoport, S. I., and Schapiro, M. B. 1999. High brain myo-inositol levels in the predementia phase of Alzheimer' disease in adults with Down syndrome: a 1H MRS study. Am. J. Psychiatry. 156:1879–1886.
Kwon, H. M., Yamauchi, A., Uchida, S., Preston, A. S., Garcia-Perez, A., Burg, M. B., and Handler, J.S. 1992. Cloning of the cDNA for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. J. Biol. Chem. 267:6297–6301.
Zhou, C., Agarwal, N., and Cammarata, P. R. 1994. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells part 2: cloning of a 626 bp cDNA portion of a Na+/myo-inositol cotransporter, an osmotic shock protein. Invest. Ophthalmol. Vis. Sci. 35:1236–1242.
Hauser, G. 1965. Energy-and sodium-dependent uptake of inositol by kidney cortex slices. Biochem. Biophys. Res. Commun. 19:696–701.
Nakanishi, T., Turner, R. J., and Burg, M. B. 1989. Osmoregulatory changes in myo-inositol transport by renal cells. Proc. Natl. Acad. Sci. USA 86:6002–6006.
Prpic, V., Blackmore, P. F., and Exton, J. H. 1982. myo-Inositol uptake and metabolism in isolated rat liver cells. J. Biol. Chem. 257:11315–11322.
Molitoris, B. A., Karl, I. E., and Daughaday, W. H. 1980. Concentration of myo-inositol in skeletal muscle of the rat occurs without active transport. J. Clin. Invest. 65:783–788.
Fisher, S. K., Heacock, A. M., and Agranoff, B. W. 1992. Inositol lipids and signal transduction in the nervous system: an update. J. Neurochem. 58:18–38.
Vilven, J., and Coronado, R. 1988. Opening of dihydropyridine calcium channels in skeletal muscle membranes by inositol trisphosphate. Nature 336:587–589.
Stokes, C. E., and Hawthorne, J. N. 1987. Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. J. Neurochem. 48:1018–1021.
Barnaby, R. J. 1991. Mass assay for inositol 1-phosphate in rat brain by high-performance liquid chromatography and pulsed amperometric detection. Anal. Biochem. 199:75–80.
Ghalayini, A. and Eichberg, J. 1985. Purification of phosphatidylinositol synthetase from rat brain by CDP-diacylglycerol affinity chromatography and properties of the purified enzyme. J. Neurochem. 44:175–182.
Guo, W., Shimada, S., Tajiri, H., Yamauchi, A., Yamashita, T., Okada, S., and Tohyama, M. 1997. Developmental regulation of Na+/myo-inositol cotransporter gene expression. Mol. Brain Res. 51:91–96.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shetty, H.U., Siarey, R.J., Galdzicki, Z. et al. Ts65Dn Mouse, a Down Syndrome Model, Exhibits Elevated myo-Inositol in Selected Brain Regions and Peripheral Tissues. Neurochem Res 25, 431–435 (2000). https://doi.org/10.1023/A:1007592006005
Issue Date:
DOI: https://doi.org/10.1023/A:1007592006005